Clark Eliana
EVP, Chief Technical Officer
Clark Eliana has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 3, 2026.
On the most recent filing, Clark Eliana is listed as EVP, Chief Technical Officer at Intellia Therapeutics, Inc. Inside the rolling window, Clark Eliana reported no open-market purchases and 2 open-market sales totaling $96K in NTLA. The largest disclosed transaction in the window is a sale of 9,515 NTLA shares on Jan 5, 2026, worth $88K.
Companies traded
Other insiders at NTLA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$96K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Clark Eliana made?
Clark Eliana has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Clark Eliana trade?
Clark Eliana has filed SEC Form 4 disclosures for 1 company, including NTLA.
When was Clark Eliana's most recent SEC Form 4 filing?
Clark Eliana's most recent SEC Form 4 filing on Tracefour is dated Mar 3, 2026.
What is Clark Eliana's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Clark Eliana is listed as EVP, Chief Technical Officer.
What is Clark Eliana's total buy and sell value in the current window?
Inside the rolling retention window, Clark Eliana bought $0 and sold $96K based on SEC Form 4 filings.
What was Clark Eliana's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 9,515 NTLA shares on 2026-01-05, worth $88K, per SEC Form 4 filings.